Wei Mao

655 total citations
20 papers, 517 citations indexed

About

Wei Mao is a scholar working on Molecular Biology, Cancer Research and Pharmacology. According to data from OpenAlex, Wei Mao has authored 20 papers receiving a total of 517 indexed citations (citations by other indexed papers that have themselves been cited), including 10 papers in Molecular Biology, 5 papers in Cancer Research and 4 papers in Pharmacology. Recurrent topics in Wei Mao's work include Metabolomics and Mass Spectrometry Studies (2 papers), Genomics, phytochemicals, and oxidative stress (2 papers) and Cancer, Hypoxia, and Metabolism (2 papers). Wei Mao is often cited by papers focused on Metabolomics and Mass Spectrometry Studies (2 papers), Genomics, phytochemicals, and oxidative stress (2 papers) and Cancer, Hypoxia, and Metabolism (2 papers). Wei Mao collaborates with scholars based in China, Hong Kong and Ethiopia. Wei Mao's co-authors include Chen Xie, Peng Xu, Tuan Guo, Xing Liang, Yunyun Huang, Bai‐Ou Guan, Fu Liu, Jacques Albert, Ji Zhu and Dezhao Lu and has published in prestigious journals such as SHILAP Revista de lepidopterología, Scientific Reports and Frontiers in Immunology.

In The Last Decade

Wei Mao

18 papers receiving 510 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Wei Mao China 11 203 142 109 69 63 20 517
Huasheng Liang China 13 234 1.2× 79 0.6× 64 0.6× 14 0.2× 82 1.3× 23 535
Chen Xuan China 11 201 1.0× 23 0.2× 57 0.5× 28 0.4× 61 1.0× 42 426
Zhou Cai China 12 186 0.9× 62 0.4× 18 0.2× 31 0.4× 61 1.0× 24 486
Pan Cheng China 14 136 0.7× 148 1.0× 16 0.1× 15 0.2× 49 0.8× 38 638
Junhao Jiang China 16 211 1.0× 27 0.2× 90 0.8× 11 0.2× 34 0.5× 94 838
Jinjin Xu China 12 174 0.9× 23 0.2× 40 0.4× 16 0.2× 74 1.2× 23 544
Keke Ding China 14 175 0.9× 19 0.1× 133 1.2× 15 0.2× 76 1.2× 35 472
Xiaohu Chen China 15 232 1.1× 14 0.1× 78 0.7× 60 0.9× 96 1.5× 55 676

Countries citing papers authored by Wei Mao

Since Specialization
Citations

This map shows the geographic impact of Wei Mao's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Wei Mao with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Wei Mao more than expected).

Fields of papers citing papers by Wei Mao

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Wei Mao. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Wei Mao. The network helps show where Wei Mao may publish in the future.

Co-authorship network of co-authors of Wei Mao

This figure shows the co-authorship network connecting the top 25 collaborators of Wei Mao. A scholar is included among the top collaborators of Wei Mao based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Wei Mao. Wei Mao is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Chen, Wei, Wei Mao, Yuan Fang, et al.. (2025). NAT10-mediated lipid metabolic reprogramming drives EGFR-TKI resistance in non-small cell lung cancer via ac4C-dependent mRNA stabilization. Experimental Hematology and Oncology. 14(1). 134–134.
2.
Wu, Shouhai, Kaiyuan Ji, Tongxiang Lin, et al.. (2024). Chinese medicine PaBing-II protects human iPSC-derived dopaminergic neurons from oxidative stress. Frontiers in Immunology. 15. 1410784–1410784.
3.
Mao, Wei, Chen Huang, Liqi Zhou, et al.. (2024). Multi-Convergence-Angle Ptychography with Simultaneous Strong Contrast and High Resolution. SHILAP Revista de lepidopterología. 129. 4014–4014. 3 indexed citations
4.
5.
6.
Lu, Dezhao, et al.. (2021). CLIC1 Inhibition Protects Against Cellular Senescence and Endothelial Dysfunction Via the Nrf2/HO-1 Pathway. Cell Biochemistry and Biophysics. 79(2). 239–252. 17 indexed citations
7.
8.
Gu, Yue-Yu, Fuhua Lu, Xiao‐Ru Huang, et al.. (2021). Non-Coding RNAs as Biomarkers and Therapeutic Targets for Diabetic Kidney Disease. Frontiers in Pharmacology. 11. 583528–583528. 44 indexed citations
9.
Wang, Xiaowan, Ruimin Tian, Yiqi Yang, et al.. (2019). Triptriolide antagonizes triptolide-induced nephrocyte apoptosis via inhibiting oxidative stress in vitro and in vivo. Biomedicine & Pharmacotherapy. 118. 109232–109232. 19 indexed citations
10.
Ma, Lan, et al.. (2018). Research Progress of Angiogenesis in Atherosclerotic Plaque in Chinese Medicine and Western Medicine. Chinese Journal of Integrative Medicine. 24(12). 950–955. 3 indexed citations
11.
Yang, Yiqi, Kai Wang, Ruimin Tian, et al.. (2018). Triptriolide Alleviates Lipopolysaccharide-Induced Liver Injury by Nrf2 and NF-κB Signaling Pathways. Frontiers in Pharmacology. 9. 999–999. 44 indexed citations
12.
Yang, Jinxiu, et al.. (2018). Endothelial progenitor cells in age-related vascular remodeling. Cell Transplantation. 27(5). 786–795. 48 indexed citations
13.
Zhu, Ji, Linwensi Zhu, Jinhuan Yang, et al.. (2018). Proteomic analysis of human umbilical vein endothelial cells exposed to PM2.5. Journal of Zhejiang University SCIENCE B. 19(6). 458–470. 5 indexed citations
14.
Li, Shasha, Peng Xu, Ling Han, et al.. (2017). Disease-syndrome combination modeling: metabolomic strategy for the pathogenesis of chronic kidney disease. Scientific Reports. 7(1). 8830–8830. 8 indexed citations
15.
Zhu, Ji, Yingling Xu, Xiao Hu, et al.. (2017). Tanshinone IIA Sodium sulfonate regulates antioxidant system, inflammation, and endothelial dysfunction in atherosclerosis by downregulation of CLIC1. European Journal of Pharmacology. 815. 427–436. 69 indexed citations
16.
Ye, Libing & Wei Mao. (2016). Metabonomic biomarkers for risk factors of chronic kidney disease. International Urology and Nephrology. 48(4). 547–552. 18 indexed citations
17.
Guo, Tuan, Chen Xie, Peng Xu, et al.. (2016). Specific Detection of Aquaporin-2 Using Plasmonic Tilted Fiber Grating Sensors. Journal of Lightwave Technology. 35(16). 3360–3365. 36 indexed citations
18.
Guo, Tuan, Fu Liu, Xing Liang, et al.. (2015). Highly sensitive detection of urinary protein variations using tilted fiber grating sensors with plasmonic nanocoatings. Biosensors and Bioelectronics. 78. 221–228. 141 indexed citations
19.
Liang, Xing, Wei Mao, & Xusheng Liu. (2013). Progress on the application of aquaporins in Chinese medicine. Chinese Journal of Integrative Medicine. 19(7). 556–559. 1 indexed citations
20.
Yin, Xiaofei, Jie Chen, Wei Mao, Yuhong Wang, & Minhu Chen. (2013). Downregulation of aryl hydrocarbon receptor expression decreases gastric cancer cell growth and invasion. Oncology Reports. 30(1). 364–370. 28 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Huasheng Liang Breakdown of academic impact, for papers by Chen Xuan Breakdown of academic impact, for papers by Zhou Cai Breakdown of academic impact, for papers by Pan Cheng Breakdown of academic impact, for papers by Junhao Jiang Breakdown of academic impact, for papers by Jinjin Xu Breakdown of academic impact, for papers by Keke Ding Breakdown of academic impact, for papers by Xiaohu Chen
Rankless by CCL
2026